Family · Pharmaceutical analytical standards
Paroxetine
An antidepressant of the selective serotonin reuptake inhibitor (SSRI) class, developed in Denmark in the 1970s and approved in the United States in 1992: it is used for depression, panic attacks and anxiety disorders. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?In 2012 researchers at the University of Michigan discovered, purely by chance, that it also inhibits GRK2, a kinase involved in heart failure: in animal models it strengthened heart contractions.
No product matches your search.
EDQM standards 8
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
